SILVAGNI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 4.593
AS - Asia 3.318
EU - Europa 1.507
SA - Sud America 490
AF - Africa 294
Continente sconosciuto - Info sul continente non disponibili 209
OC - Oceania 31
AN - Antartide 1
Totale 10.443
Nazione #
US - Stati Uniti d'America 4.351
SG - Singapore 1.031
IT - Italia 650
CN - Cina 556
VN - Vietnam 294
BR - Brasile 279
BD - Bangladesh 243
HK - Hong Kong 229
ID - Indonesia 164
IN - India 163
DE - Germania 160
GB - Regno Unito 160
EG - Egitto 158
JP - Giappone 127
FR - Francia 108
CA - Canada 103
IQ - Iraq 97
MX - Messico 91
FI - Finlandia 82
TR - Turchia 70
NL - Olanda 56
EC - Ecuador 54
RU - Federazione Russa 52
PK - Pakistan 49
PH - Filippine 44
IR - Iran 43
ZA - Sudafrica 42
AR - Argentina 40
PL - Polonia 38
SA - Arabia Saudita 38
CO - Colombia 31
MY - Malesia 31
ES - Italia 30
AU - Australia 29
TW - Taiwan 28
KR - Corea 27
PE - Perù 27
UA - Ucraina 27
AT - Austria 22
BO - Bolivia 19
KE - Kenya 19
CZ - Repubblica Ceca 18
SE - Svezia 18
VE - Venezuela 16
CL - Cile 15
CH - Svizzera 13
NG - Nigeria 12
BE - Belgio 11
DZ - Algeria 11
JM - Giamaica 11
MA - Marocco 11
JO - Giordania 10
HU - Ungheria 9
LY - Libia 9
RO - Romania 8
TN - Tunisia 8
CR - Costa Rica 7
IE - Irlanda 7
IL - Israele 7
PS - Palestinian Territory 7
HN - Honduras 6
KZ - Kazakistan 6
NP - Nepal 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
LB - Libano 5
LT - Lituania 5
OM - Oman 5
PA - Panama 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
UZ - Uzbekistan 5
AL - Albania 4
DK - Danimarca 4
ET - Etiopia 4
LV - Lettonia 4
MG - Madagascar 4
AZ - Azerbaigian 3
LK - Sri Lanka 3
MM - Myanmar 3
PR - Porto Rico 3
PT - Portogallo 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
VC - Saint Vincent e Grenadine 3
BF - Burkina Faso 2
BG - Bulgaria 2
CD - Congo 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
LS - Lesotho 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
Totale 10.210
Città #
Ashburn 643
Singapore 621
San Jose 524
Dallas 372
Council Bluffs 272
Santa Clara 265
Hong Kong 205
Beijing 197
Los Angeles 140
Fairfield 108
New York 105
Chandler 103
Ho Chi Minh City 103
Tokyo 99
Jakarta 85
Hanoi 75
Woodbridge 65
Houston 54
Milan 53
Alexandria 52
Helsinki 52
Lauterbourg 52
Seattle 51
Ferrara 47
Cairo 46
Baghdad 45
Buffalo 41
Chicago 40
Wilmington 40
Shanghai 39
Cambridge 37
Rome 37
London 35
Mexico City 35
Bologna 34
Munich 34
Toronto 34
Ann Arbor 33
Orem 33
Warsaw 33
Montreal 32
São Paulo 32
Atlanta 30
Princeton 28
Naples 26
Frankfurt am Main 24
Hefei 24
Brooklyn 23
Lappeenranta 21
Phoenix 21
Boston 20
Jacksonville 20
Denver 19
Poplar 19
Falkenstein 18
Izmir 18
Johannesburg 18
Manchester 18
Nanjing 18
San Francisco 18
Da Nang 17
Lima 17
Quito 17
Chennai 15
Kuala Lumpur 15
Miami 15
Najaf 15
Sydney 15
Ankara 14
Nairobi 14
San Diego 14
Athens 13
New Delhi 13
Nuremberg 13
Padova 13
Riyadh 13
Amsterdam 12
Haiphong 12
Lahore 12
Mumbai 12
Secaucus 12
Charlotte 11
City of London 11
Columbus 11
Cuenca 11
Guayaquil 11
La Paz 11
Stockholm 11
Cincinnati 10
Delhi 10
Elk Grove Village 10
Hillah 10
Melbourne 10
Moscow 10
Rio de Janeiro 10
Surabaya 10
Tanta 10
The Dalles 10
Vienna 10
Budapest 9
Totale 5.875
Nome #
Systemic lupus erythematosus: one year in review 2023 982
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 453
Novel insights into the management of rheumatoid arthritis: one year in review 2022 300
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 289
Novel insights into the management of rheumatoid arthritis: one year in review 2023 278
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 268
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 256
Biological and synthetic target DMARDs in psoriatic arthritis 215
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 206
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 202
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 201
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 199
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 187
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 187
Systemic lupus erythematosus: one year in review 2024 186
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 185
Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology 184
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 170
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 167
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 165
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 163
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 163
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 162
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 161
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 160
Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology 156
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 154
Features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (CPPD) disease: study using data from the international ACR/EULAR CPPD classification criteria cohort 152
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 150
One year in review 2018: novelties in the treatment of rheumatoid arthritis 149
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 147
Tofacitinib improves mitochondrial function in psoriatic arthritis fibroblast-like synoviocytes via autophagy modulation 147
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 147
Neurologic Involvement in Rheumatic Diseases 144
Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis 142
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy Subjects 141
Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology 139
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 137
Systemic lupus erythematosus: one year in review 2025 131
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 130
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 128
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 127
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease 112
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease 105
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 103
Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology 102
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology 101
Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review 98
Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology 97
One year in review 2019: novelties in the treatment of rheumatoid arthritis 94
One year in review 2021: novelties in the treatment of rheumatoid arthritis 94
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 90
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases 87
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage 81
One year in review 2020: novelties in the treatment of rheumatoid arthritis 77
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study 77
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort 69
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0) 62
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review 62
Role of musculoskeletal ultrasound in diagnosing and managing chronic inflammatory arthritis in overweight and obese patients: a narrative review 60
Systemic lupus erythematosus: one year in review 2026 59
Early antiproteinuric effect of voclosporin in patients with lupus nephritis in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience 59
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 52
Assessing the sensitivity and the clinical impact of the 2023 ACR/EULAR classification criteria in Obstetric Antiphospholid Syndrome: findings from a multicenter Italian cohort with a long-term follow-up 33
Distinct pattern of comorbidities hinders treatment target attainment in SLE through persistent disease activity and delayed glucocorticoid tapering: longitudinal data from a multicentre cohort study 31
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study 30
Shaping rheumatoid arthritis treatment: Clinical and demographic drivers of tsDMARDs versus bDMARDs prescription post-EMA pronouncement on JAK inhibitors. Insights from the AMBI-RA study 26
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort 25
Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities. 19
Voclosporin for the treatment of lupus nephritis flares in patients with inadequate response to mycophenolate mofetil and belimumab: a case series 10
A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus 10
Reconsidering the interpretation of prescribing shifts and treatment response in the AMBI-RA study. Authors' reply 8
Totale 10.443
Categoria #
all - tutte 45.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 432
Totale 45.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 0 10 11 10 6 29 21 16 8 14 76
2022/2023245 26 32 15 18 39 17 6 21 27 4 20 20
2023/2024610 21 23 13 8 56 6 9 18 25 140 115 176
2024/20252.172 82 150 200 140 222 252 96 110 343 195 226 156
2025/20265.760 431 210 622 498 784 291 618 331 508 618 521 328
2026/2027932 454 276 202 0 0 0 0 0 0 0 0 0
Totale 10.443